Article Text

Download PDFPDF
ATL
  1. Cheng-Chang Chang, MD*,,,
  2. Rui-Lan Huang, PhD,§,
  3. Hui-Chen Wang, BS,
  4. Yu-Ping Liao, MS,
  5. Mu-Hsien Yu, MD, PhD* and
  6. Hung-Cheng Lai, MD, PhD*,,,§
  1. *Department of Obstetrics and Gynecology, Tri-Service General Hospital;
  2. Laboratory of Epigenetics and Cancer Stem Cells, and
  3. Graduate Institute of Medical Sciences, National Defense Medical Center; and
  4. §Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan, Republic of China.
  1. Address correspondence and reprint requests to Hung-Cheng Lai, MD, PhD, Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, 5F, No. 325, Sec 2, Cheng-Gong Rd, Neihu District, Taipei City 114, Taiwan, Republic of China. Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University, No.291, Zhongzheng Rd., Zhonghe District, New Taipei City, 23561, Taiwan. E-mail: hclai{at}ndmctsgh.edu.tw.

Abstract

Objective This study aimed to investigate the status of DNA methylation of 6 genes, LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582, previously found from squamous cell carcinomas in adenocarcinomas (ACs) of the uterine cervix.

Methods We assessed the methylation status of these genes in 40 ACs, cervical scrapings from 23 ACs, and 67 normal control cervices by real-time quantitative methylation-specific polymerase chain reaction. The results were validated by bisulfite pyrosequencing.

Results The methylation levels of all the 6 genes in the ACs were significantly higher than those in normal cervical tissues, especially for PAX1, PTPRR, SOX1, and ZNF582. The odds ratios and 95% confidence intervals (CIs) of high methylation levels in PAX1, PTPRR, SOX1, and ZNF582 for the risk of developing an AC were 15.7 (95% CI, 7.0–40.6), 16.9 (95% CI, 7.6–43.0), 32.1 (95% CI, 12.1–124.3), and 25.4 (95% CI, 10.4–78.3), respectively (all P < 0.001). The methylation indices of PAX1, PTPRR, SOX1, and ZNF582 recovered from scrapings of ACs were significantly higher than in normal controls. The odds ratios of these indices for the risk of developing an AC in PAX1, PTPRR, SOX1, and ZNF582 were 6.2 (95% CI, 2.6–15.4), 12.1(95% CI, 3.8–46.4), 6.2 (95% CI, 2.6–15.8), and 20.6 (95% CI, 6.9–77.5), respectively (all P < 0.001).

Conclusions Cervical ACs carry aberrantly high methylation rates of PAX1, PTPRR, SOX1, and ZNF582—commonly methylated in squamous cell carcinomas—which might help for AC screening.

  • Adenocarcinoma of the cervix
  • Bisulfite pyrosequencing
  • DNA methylation
  • Real-time quantitative methylation-specific PCR

Statistics from Altmetric.com

Footnotes

  • This work was supported in part by the following grants: TSGH-C96-2-S01-4 from the Tri-Service General Hospital, NSC95-2622-B-016-001 and NSC95-2314-B-016-058-MY2 from the National Science Council, Republic of China, and the Teh-Tzer Study Group for Human Medical Research Foundation.

  • Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.ijgc.net).

  • The authors declare no conflicts of interest.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.